RadioVal

Name of the project: International Clinical Validation of Radiomics Artificial Intelligence for Breast Cancer Treatment Planning (RadioVal)

Principal investigator (PI): Lekadir, Karim

Funding entity: Unió Europea

Duration: 01/09/2022 - 31/08/2026

The idea of the RadioVal project is to develop and implement a very comprehensive validation of artificial intelligence solutions in the breast cancer treatment. We hope our projects promotes precision medicine with tools that will help clinicians to perform more precise medicine, individualised to the patient’s need. RadioVal will help clinicians help patients.

RadioVal implements the first international, clinical validation study of radiomics-based prediction of neoadjuvant chemotherapy treatment response from breast MRI. The project will develop a comprehensive and standardised methodological framework for multi-faceted radiomics evaluation based on the FUTURE-AI Guidelines, to assess Fairness, Universality, Traceability, Usability, Robustness and Explainability. Furthermore, the project will introduce new tools to enable transparent and continuous evaluation and monitoring of the radiomics tools over time. The RadioVal study will be implemented through a multi-stakeholder approach, taking into account clinical and healthcare needs, as well as socio-ethical and regulatory requirements from day one.

Click Here For More Information.

Members involved

Research lines